Effect of sinoaortic deafferentation on renal wrap hypertension
Hypertension, ISSN: 0194-911X, Vol: 33, Issue: 1 II, Page: 476-481
1999
- 18Citations
- 84Usage
- 12Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations18
- Citation Indexes18
- 18
- CrossRef11
- Usage84
- Downloads61
- Abstract Views23
- Captures12
- Readers12
- 12
Article Description
The purpose of this study was to determine whether sinoaortic deafferentation (SAD) alters the severity of hypertension or sympathoadrenal contribution to mean blood pressure (MAP) during renal wrap hypertension. Male Sprague-Dawley rats were implanted with radiotelemetry transmitters for 24-hour recording of MAP and heart rate. All rats underwent either SAD or sham SAD (Intact) surgery and were allowed to recover for 10 to 14 days. The rats were then assigned to a normotensive (Sham) group or a hypertensive (Wrap) group in which 1-kidney figure-8 renal wrap was performed. SAD increased the acute MAP response to renal wrap (Intact-Sham=5±1 mm Hg, Intact-Wrap=45±3 mm Hg,: SAD-Sham=3±3 mm Hg, SAD-Wrap=58±4 mm Hg) and increased the lability of MAP (SD of MAP; Intact-Sham=3.8±0.2, Intact- Wrap=4.2±0.3, SAD-Sham=9.6±1.4, SAD-Wrap=9.7±1.4). MAP was not different between SAD and Intact rats during 4 weeks after renal wrap or sham surgery; however, induction of hypertension produced additional MAP variability that was independent of SAD (Intact-Sham=4.6±0.4, Intact-Wrap=6.2±0.6, SAD- Sham=6.3±0.5, SAD-Wrap=10.8±1.5). In a separate group of rats, the sympathoadrenal contribution to MAP was assessed by the depressor response to ganglionic blockade and plasma norepinephrine at rest and after neuronal uptake inhibition with desipramine. The depressor response to ganglionic blockade was significantly increased by renal wrap and by SAD (Intact-Sham=- 49±2 mm Hg, Intact-Wrap=-73±4 mm Hg, SAD-Sham=-77±5 mm Hg, SAD, Wrap=- 96±6 mm Hg). In the 3 groups with enhanced ganglionic blockade responses, desipramine caused a significant increase in plasma norepinephrine. These results indicate that SAD does not alter the development of renal wrap hypertension but does increase the sympathoadrenal contribution to MAP in both normotensive and hypertensive animals.
Bibliographic Details
https://scholarlycommons.pacific.edu/cop-facarticles/450; https://scholarlycommons.pacific.edu/cop-facarticles/451
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0032957702&origin=inward; http://dx.doi.org/10.1161/01.hyp.33.1.476; http://www.ncbi.nlm.nih.gov/pubmed/9931151; https://www.ahajournals.org/doi/10.1161/01.HYP.33.1.476; https://scholarlycommons.pacific.edu/cop-facarticles/450; https://scholarlycommons.pacific.edu/cgi/viewcontent.cgi?article=1459&context=cop-facarticles; https://scholarlycommons.pacific.edu/cop-facarticles/451; https://scholarlycommons.pacific.edu/cgi/viewcontent.cgi?article=1460&context=cop-facarticles; http://hyper.ahajournals.org/cgi/doi/10.1161/01.HYP.33.1.476; https://www.ahajournals.org/doi/abs/10.1161/01.HYP.33.1.476
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know